The abstract is read at the publisher; the summary is JClub's.
PDAC BioPortal integrates 349 TCGA-GTEx, treatment, single-nucleus, and spatial PDAC transcriptomic datasets, enabling cross-context discovery of disease- and therapy-linked programs.
- Why it matters: Public PDAC transcriptomic resources are fragmented across modalities, blocking integrated analysis of molecular programs across scales and cellular compartments.
- What they did: The platform unifies bulk RNA-seq, a 55-specimen treatment cohort (GSE225767), a 224,988-nucleus single-nucleus atlas (GSE202051), and 23,436 spatial spots (GSE274103), with interactive differential expression, enrichment, pseudobulk, cell-type, and spatial visualization plus an evidence-grounded natural-language interface.
- The result: Primary PDAC shows proliferation, inflammatory, and epithelial-mesenchymal transition programs, while neoadjuvant chemotherapy plus SBRT shows mesenchymal, collagen, and extracellular matrix signatures; NRF2-associated redox programs are linked to shorter overall survival in an exploratory analysis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.